How does Sitagliptin compare to newer antidiabetic agents in terms of efficacy, safety, and patient outcomes?
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Sitagliptin compare to newer antidiabetic agents in terms of efficacy, safety, and patient outcomes?
Sitagliptin shows comparable efficacy in glycemic control to newer agents but may have fewer gastrointestinal side effects than GLP-1 agonists. It also poses a lower risk of hypoglycemia compared to sulfonylureas.